Xwell (XWEL) Notes Payables (2011 - 2025)

Xwell (XWEL) posted Notes Payables of $3.6 million for Q4 2025, up 427.17% sequentially from $681000.0 in Q3 2020.

Xwell (XWEL) Notes Payables (2011 - 2025) Analysis & Trends

Xwell has reported Notes Payables for 8 years, with the latest figure at $3.6 million in Q4 2025.

Quarterly Notes Payables changed N/A year-over-year to $3.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.6 million (changed N/A YoY) and the FY2025 annual result came in at $3.6 million, changed N/A from the prior year.
Notes Payables grew to $3.6 million in Q4 2025 per XWEL's latest filing, from $681000.0 in the prior quarter.
Over five years, Notes Payables peaked at $3.6 million in Q4 2025 and troughed at $3.6 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn
10	Xwell	8.44 Mn	-3.33 Mn	2.95 Mn

Download Data